These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 5577482)
1. The choreoathetoid movement disorder induced by levodopa. Markham CH Clin Pharmacol Ther; 1971; 12(2):340-3. PubMed ID: 5577482 [No Abstract] [Full Text] [Related]
2. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342 [No Abstract] [Full Text] [Related]
3. Start hesitation--a side effect of long-term levodopa therapy. Ambani LM; Van Woert MH N Engl J Med; 1973 May; 288(21):1113-5. PubMed ID: 4697941 [No Abstract] [Full Text] [Related]
4. [Problems and therapy of L-DOPA-induced dyskinesias]. Völler GW; Deze J; Gundlach U; Muschard F Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994 [No Abstract] [Full Text] [Related]
6. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586 [No Abstract] [Full Text] [Related]
7. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis. Chase TN; Holden EM; Brody JA Arch Neurol; 1973 Nov; 29(5):328-33. PubMed ID: 4743883 [No Abstract] [Full Text] [Related]
9. Psychosis and other psychiatric manifestations of levodopa therapy. Celesia GG; Barr AN Arch Neurol; 1970 Sep; 23(3):193-200. PubMed ID: 5456717 [No Abstract] [Full Text] [Related]
10. Adverse reactions during treatment of Parkinson's disease with levodopa. Martin WE JAMA; 1971 Jun; 216(12):1979-83. PubMed ID: 5314258 [No Abstract] [Full Text] [Related]
16. Deanol in the treatment of levodopa-induced dyskinesias. Miller E Neurology; 1974 Feb; 24(2):116-9. PubMed ID: 4855678 [No Abstract] [Full Text] [Related]
17. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone). Dupont E; Hansen E; Melsens S; Parkenberg H; Holm P Acta Neurol Scand Suppl; 1972; 51():115-7. PubMed ID: 4514334 [No Abstract] [Full Text] [Related]
18. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ; Somerville B Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
19. Failures of L-dopa. Paulson GW Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406 [No Abstract] [Full Text] [Related]
20. Side effects of L-dopa treatment. Greenburg J Pa Med; 1971 Apr; 74(4):55-6. PubMed ID: 5147645 [No Abstract] [Full Text] [Related] [Next] [New Search]